Innovation in therapeutics development at the NCATS.
作者信息
Colvis Christine M, Austin Christopher P
机构信息
National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
出版信息
Neuropsychopharmacology. 2014 Jan;39(1):230-2. doi: 10.1038/npp.2013.247.
Abstract
摘要
相似文献
1
Innovation in therapeutics development at the NCATS.美国国立转化医学推进中心（NCATS）在治疗学开发方面的创新。
Neuropsychopharmacology. 2014 Jan;39(1):230-2. doi: 10.1038/npp.2013.247.
2
From the editors' desk: Why NCATS should read this issue of JGIM.编者按：美国国立转化医学推进中心（NCATS）为何应阅读本期《普通内科医学杂志》（JGIM）。
J Gen Intern Med. 2012 Jun;27(6):613-4. doi: 10.1007/s11606-012-2055-z.
3
Gene Therapy: The View from NCATS.基因疗法：美国国立转化医学科学研究所的观点
Hum Gene Ther. 2016 Jan;27(1):7-13. doi: 10.1089/hum.2016.29018.pjb.
4
Translational research: Medicine man.转化医学：医学专家。
Nature. 2013 Feb 7;494(7435):24-6. doi: 10.1038/494024a.
5
Deconstructing the Translational Tower of Babel.解构翻译中的巴别塔
Clin Transl Sci. 2019 Mar;12(2):85. doi: 10.1111/cts.12595. Epub 2018 Nov 9.
6
Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise.2020年临床转化科学：颠覆性创新重新定义了发现应用型企业。
Clin Transl Sci. 2011 Feb;4(1):69-71. doi: 10.1111/j.1752-8062.2011.00261.x.
7
Toward A Universal Biomedical Data Translator.迈向通用生物医学数据翻译器。
Clin Transl Sci. 2019 Mar;12(2):86-90. doi: 10.1111/cts.12591. Epub 2018 Nov 9.
8
Advancing translational research.推进转化研究。
Science. 2011 Mar 25;331(6024):1516-7. doi: 10.1126/science.331.6024.1516-b.
9
The Biomedical Data Translator Program: Conception, Culture, and Community.生物医学数据翻译计划：概念、文化与社群
Clin Transl Sci. 2019 Mar;12(2):91-94. doi: 10.1111/cts.12592. Epub 2018 Nov 9.
10
National Institutes of Health seek to speed up therapeutic innovations.美国国立卫生研究院寻求加速治疗创新。
CMAJ. 2011 Feb 8;183(2):E91-2. doi: 10.1503/cmaj.109-3777. Epub 2011 Jan 10.
引用本文的文献
1
A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.集成资源工作流程以促进基于网络药理学的 COVID-19 研究。
J Chem Inf Model. 2022 Feb 14;62(3):718-729. doi: 10.1021/acs.jcim.1c00431. Epub 2022 Jan 20.
2
A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.促进网络药理学驱动的COVID-19研究的综合资源工作流程。
bioRxiv. 2020 Nov 5:2020.11.04.369041. doi: 10.1101/2020.11.04.369041.
3
The future of translational research on alcohol use disorder.酒精使用障碍转化研究的未来。
Addict Biol. 2021 Mar;26(2):e12903. doi: 10.1111/adb.12903. Epub 2020 Apr 14.
4
Predicting translational progress in biomedical research.预测生物医学研究中的转化进展。
PLoS Biol. 2019 Oct 10;17(10):e3000416. doi: 10.1371/journal.pbio.3000416. eCollection 2019 Oct.
5
The price of progress: Funding and financing Alzheimer's disease drug development.进步的代价：阿尔茨海默病药物研发的资金与融资
Alzheimers Dement (N Y). 2018 Jun 13;4:330-343. doi: 10.1016/j.trci.2018.04.008. eCollection 2018.
6
Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.阿尔茨海默病的疾病修饰治疗临床试验：入门、经验教训和未来蓝图。
J Alzheimers Dis. 2018;64(s1):S3-S22. doi: 10.3233/JAD-179901.
7
Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public-private partnerships.通过公私合作促进微生理系统（组织芯片）项目所产生的器官平台的商业化及应用。
Comput Struct Biotechnol J. 2016 May 10;14:207-210. doi: 10.1016/j.csbj.2016.04.003. eCollection 2016.
8
The Rescue and Repurposing of Pharmaceuticals: Augmenting the Drug Development Paradigm.药物的抢救与重新利用：拓展药物开发模式
J Pediatr Pharmacol Ther. 2016 Jan-Feb;21(1):4-6. doi: 10.5863/1551-6776-21.1.4.
本文引用的文献
1
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.美西律治疗非营养不良性肌强直的症状和体征：一项随机对照试验。
JAMA. 2012 Oct 3;308(13):1357-65. doi: 10.1001/jama.2012.12607.
2
Diagnosing the decline in pharmaceutical R&D efficiency.诊断制药研发效率下降。
Nat Rev Drug Discov. 2012 Mar 1;11(3):191-200. doi: 10.1038/nrd3681.
3
Translating discoveries into medicine: psychiatric drug development in 2011.将科研成果转化为医学应用：2011年精神科药物研发进展
Neuropsychopharmacology. 2012 Jan;37(1):281-3. doi: 10.1038/npp.2011.106.
4
Mining for therapeutic gold.挖掘治疗性黄金。
Nat Rev Drug Discov. 2011 Jun;10(6):397. doi: 10.1038/nrd3461.
5
Can the pharmaceutical industry reduce attrition rates?制药行业能降低损耗率吗？
Nat Rev Drug Discov. 2004 Aug;3(8):711-5. doi: 10.1038/nrd1470.
Zotero 插件